Deva Holding AS is recalling approximately 54,768 bottles of Temozolomide capsules (generic for Temodar) across six different strengths (5 mg, 20 mg, 100 mg, 140 mg, 180 mg, and 250 mg). The recall was initiated because the manufacturing facility failed to prevent potential cross-contamination with beta-lactam products (such as penicillin or cephalosporin antibiotics). If these chemotherapy capsules contain traces of antibiotics, patients with severe allergies could experience a dangerous reaction.
The product may be contaminated with beta-lactam antibiotics. Patients who are highly sensitive or allergic to penicillin or other beta-lactams could suffer severe, potentially life-threatening allergic reactions if they consume this medication.
Full refund for unused prescription medication.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.